PCPA in the news – Unveiling the power of empathy: Gilead joins oncologists in bridging the gap

/in , /by

Health Industry Hub 26 May 2023

Pharma News: In an event that showcased the cutting-edge advancements in cancer treatment, the Private Cancer Physicians of Australia (PCPA) joined forces with GenesisCare, their Strategic Alliance Partner, to successfully launch the inaugural PCPA Live Multidisciplinary Teams (MDT) Masterclass. This event witnessed healthcare leaders from Gilead Australia immerse themselves in the daily life of breast cancer patients undergoing complex treatments, providing a unique opportunity to gain invaluable insights into the challenges faced by patients and their MDT teams.

Under the esteemed guidance of PCPA Board member and renowned GenesisCare Medical Oncologist, Professor Stephen Clarke, alongside esteemed colleagues Dr Katrina Moore and Dr Sally Baron-Hay, more than 15 industry leaders in cancer care came together at the North Shore Campus in Sydney. This facility, which encompasses both GenesisCare and the prestigious Royal North Shore Hospital, served as the perfect setting for the interactive Masterclass.

Click here to read the full article.

PCPA in the news – Leaders get up close in cancer care

/in , /by

pharma in focus 26th May 2023

Gilead leaders attended a newly launched Multidisciplinary Teams (MDT) Masterclass in cancer treatment this week hailed as an “immersive experience” to help deliver better outcomes for breast cancer patients.

The two-day interactive masterclass is an initiative of the peak body for private cancer clinicians, Private Cancer Physicians of Australia (PCPA) and its strategic alliance partner, GenesisCare.

It was held at the North Shore Campus in Sydney, which incorporates GenesisCare and Royal North Shore Hospital.

Click here to read the full article.

PCPA in the news – Gilead joins Private Cancer Physicians of Australia for launch of Live MDT Masterclass

/in , /by

Bio Pharma Dispatch 25 May 2023

The inaugural PCPA Live Multidisciplinary Teams (MDT) Masterclass in cancer treatment was launched this week by the peak body for private cancer clinicians and its strategic partner
GenesisCare.

Under the leadership of PCPA Board member and leading GenesisCare Medical Oncologist, Professor Stephen Clarke and his colleagues, participants from Gilead experienced, first-hand, what a day in the life of a breast cancer patient, undergoing complex treatment, really entails for them and their MDT teams.

 

 

 

Click here to read the full article.

PCPA in the news – Big names meet to talk cancer

/in , /by

pharma in focus 4th May 2023.

Big names are readying to debate “the true value of oncology” at the Private Cancer Physicians of Australia’s (PCPA) 2023 conference over the weekend in Melbourne – just days ahead of the 2023-24 Federal Budget.

The ‘Embracing the Challenge: Advancing Cancer Care’ conference will be held at the InterContinental hotel, The Rialto, and is sponsored by a range of pharma’s including Diamond Sponsor Roche and Gold Sponsors  Gilead, Kite, and Servier.

Click here to read the full article.

PCPA in the news – Private Cancer physicians partner with industry on new patient-focused platform

/in , /by

BioPharmaDispath 27 Feb 2023.

Australia’s peak body of private cancer specialists has partnered with companies to launch a suite of interactive education and engagement platforms with the aim of enhancing the cancer care journey for patients.

The president of the Private Cancer Physicians of Australia (PCPA), Associate Professor Christopher Steer, said prioritising the needs of Australians with cancer, and those who care for them, was the driving force behind the organisation’s inaugural ‘Strategic Alliance Partnership’ program.

Click here to read full article.

PCPA in the news – Company backs cancer podcast

/in , /by

Pharma in Focus 28 Feb 2023.

The Private Cancer Physicians of Australia (PCPA) has kicked off its Strategic Alliance Partnership program with a podcast supported by Servier.

Outgoing CEO of Servier Australia, Brad Lloyd, said the company was proud to be a founding Strategic Partner with the PCPA, which aims to advance the cancer care journey of Australians, particularly through the private system. “We’re committed to improving the lives of all Australian cancer patients today and working together to develop better treatments for tomorrow,” Lloyd said.

Click here to read full article.

 

Renew your membership now and receive a free gift.*

/in /by

Current PCPA members are now able to renew your membership for 2022- 2023.

Renewing your membership is easy online by clicking on the below link
https://www.pcpa.org.au/memberships/manage-account/#myaccount

Plus for a limited time only, we are giving away one of 12 copies of “The Patient Doctor” by Dr Ben Bravery.* A powerful and inspiring memoir about how one man’s cancer diagnosis led to him becoming a doctor and advocate for change in the healthcare system.

Dr Ben Bravery spoke at the recent PCPA Advanced Trainee Program and his presentation was both inspirational and memorable.

If you require any assistance with your membership renewal, please contact PCPA Secretariat, Jennifer Burgess on j.burgess@amaq.com.au or 07 3872 2234.

*Conditions apply. While stocks last.

The Patient Doctor by Dr Ben Bravery is available to purchase online from
Hachette Australia

Election Manifesto cover

Election Manifesto

/in /by

Election Manifesto coverDate: 24 March 2022

PCPA’s core mission is the delivery of the best treatment and advocacy for patients with cancer, regardless of where they might live, or what their socioeconomic circumstances. We strive, each day, to rid the scourge of cancer from our patients and provide comfort and support to them and their families.

We are acutely aware, and deeply concerned, at the overwhelming and often, unexpected financial costs that come with the diagnosis of cancer.

As cancer physicians providing high quality, personalised, patient-centred care, we work very hard to control the out-of-pocket expenses that are within our control. As patient advocacy leaders, we see first-hand the often-extreme choices some patients feel they must make. Sell the house or have treatment? Retain childcare services or have treatment? Keep working or take the much-needed time off to recover?

Cancer treatment should never come with a question mark over whether the patient can afford it or not.

The PCPA and the Rare Cancers Australia is advocating the next Australian Government adopts the recommendations we have made in our combined ‘Cancer Care, No Gaps’ election manifesto.

Together we focus on the low cost and high impact measures that, if implemented, can and will have an immediate positive effect in the lives of Australian cancer patients and their families.

Download Election Manifesto here (PDF)

PCPA secures a reversal of MBS Telehealth cuts to phone consults

/in /by

Date: 16th January 2021

Dear Members,

We are very pleased to inform you that after a very short but intense campaign of media and advocacy over Christmas, the PCPA was able to secure a reversal of the sudden cuts to Telehealth phone consults (item number 91835).

The item will be re-instated on Tuesday January 18 and backdated to January 01, 2022. There was a further addition of MBS rebates for specialist phone consults with in-patients. We will share the full list of MBS changes when it is available.

We will continue to advocate for the re-instatement of the 50% MBS loading for video consultations with regional and rural patients (MBS item 112).

We will prepare a short letter that you should provide to your patients, impacted by this removal, so they too can become active advocates with their own local MP.

Please click here to view media release that went out on the 16th January and the joint release by Ministers Hunt and Gillespie.

View pdf of the full list of MBS items re-instated- as provided to us by Minister Hunt.